`
`MEMW
`
`mmm
`
`
`
`
`
`
`
`For additional lnforrnation about the
`
`REVLIMID REMS° program, please
`contact the Celgene Customer Care
`Center at 1 688-423-5436
`
`Download the Celgene REMS
`mobile app to your lPad by clicking
`here:
`I l l.vt»ll m n-
`
`. App Store
`
`
`
`Welcome to the REVLIMID REMS® program
`REVLIMIDo (lenalldomlde) In combination with dexamethasone is indicated for the treatment of patients with
`multiple myeloma (MM).
`
`REVLIMID is Indicated as maintenance therapy in patients with MM following autologous hematopoietlc stem cell
`transplantation (aub—HSCT).
`
`REVLIMID is indicated for the treatment of patients with transfusion-dependent anemia due to low- or
`Inhrmedlate-1—risk myelodysplastlc syndromes (MDS) associated with a deletion Sq cytogenetlc abnormality with
`or without additional cytogenetlc abnorrnalitles.
`
`REVLIMID is Indicated for the treatment of patients with mantle cell lymphoma (MCL) whose disease has
`relapsed or progressed after two prior therapies, one of which included bortezomib.
`
`important information about REVLIMID and the REVLIMID Risk Evaluation
`and Mitigation Strategy (REMS) program
`
`- REVLIMID is contraindicated in pregnant females and females capable of becoming pregnant. Females of
`reproductive potential may be treated with REVUMID provided adequate precautions are taken to avoid
`pregnancy
`- To avoid embryo-fetal exposure, REVLIMID is only available undera restricted distribution program called
`"REVLIMID REMSO”
`
`- Only prescribers and pharmacies certified by the REVLIMID REMSO program can prescribe and dspense
`REVLIMID to patients who are enrolled and meet all the conditions of the REVLIMID REMS" program
`
`The goals of the REVUMID risk evaluation and mitigation strategy are as follows:
`1. To prevent the risk of embryo-btal exposure to REVUMID
`2. To lnfonn prescribers, patients, and pharmacists on the serious risks and sale-use conditions for REVLIMID
`
`Privacy policy
`
`I Tenneof Use
`
`I Site My:
`
`I Contactue
`
`REVLIMIDo and REVLIMID REMS° are registered trademarks of Celgene Corporation.
`© 2013-2017. Celgene Corporation,Wm
`This website is intended for residents of the United States only.
`
`http:/Mw.revllmidrems.cornl
`
`1/1
`
`DR. REDDY’S LABS., INC. EX. 1070 PAGE 1
`
`DR. REDDY’S LABS., INC. EX. 1070 PAGE 1
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
